← Open Payments lookup

ASHLEY GRIFFIN: Open Payments

NPI 1942683081 · FRANKLIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$725 in 43 payments from 16 companies in 2025. Trend: 2023 $997 · 2024 $643 · 2025 $725

Food & beverage: $725
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.12$186
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$105
Novo Nordisk Inc6$91
Amgen Inc.3$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$50
GlaxoSmithKline, LLC.2$33
ABBVIE INC.2$33
AstraZeneca Pharmaceuticals LP2$32
Novartis Pharmaceuticals Corporation1$27
ANI Pharmaceuticals, Inc.1$23

Products named: Kerendia, XIFAXAN, OTEZLA, CAPLYTA, TRELEGY ELLIPTA, LEQVIO, PURIFIED CORTROPHIN GEL, Rybelsus.

Industry payments across KY — which companies pay providers there.